Dr. Camille Jackson
Claim this profileArea of expertise
Ovarian Cancer
Camille Jackson has run 1 trial for Ovarian Cancer. Some of their research focus areas include:
Clinical Trials Camille Jackson is currently running
More about Camille Jackson
Clinical Trial Related
4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Camille Jackson has experience with
- Abemaciclib
- Olaparib
Breakdown of trials Camille Jackson has run
Ovarian Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Camille Jackson specialize in?
Camille Jackson focuses on Ovarian Cancer and other conditions. In particular, much of their work with Ovarian Cancer has involved BRCA positive patients, or patients who are BRCA negative.
Is Camille Jackson currently recruiting for clinical trials?
Yes, Camille Jackson is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Camille Jackson has studied deeply?
Yes, Camille Jackson has studied treatments such as Abemaciclib, Olaparib.
What is the best way to schedule an appointment with Camille Jackson?
Apply for one of the trials that Camille Jackson is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.